TipRanks
Advertisement
Advertisement

AORT Stock Latest News

Artivion Earnings Call: Growth Drivers vs. Debt Load
Company AnnouncementsArtivion Earnings Call: Growth Drivers vs. Debt Load
2M ago
AORT
Artivion price target raised to $40 from $39 at Canaccord
PremiumThe Fly
Artivion price target raised to $40 from $39 at Canaccord
2M ago
AORT
Artivion price target lowered to $39.20 from $42 at Ladenburg
PremiumThe Fly
Artivion price target lowered to $39.20 from $42 at Ladenburg
2M ago
AORT
Artivion price target raised to $39 from $36 at Canaccord
PremiumThe Fly
Artivion price target raised to $39 from $36 at Canaccord
2M ago
AORT
Artivion reports Q2 non-GAAP EPS 13c, consensus 10c
PremiumThe Fly
Artivion reports Q2 non-GAAP EPS 13c, consensus 10c
2M ago
AORT
Artivion repeats 2026 revenue $480M-$496M, consensus $486.23M
PremiumThe FlyArtivion repeats 2026 revenue $480M-$496M, consensus $486.23M
2M ago
AORT
Artivion: NEXUS Add-On Payment Approval Strengthens U.S. Opportunity; Buy Rating and $36 Price Target Reiterated
Premium
Ratings
Artivion: NEXUS Add-On Payment Approval Strengthens U.S. Opportunity; Buy Rating and $36 Price Target Reiterated
2M ago
AORT
AORT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AORT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
AORT
Artivion Earns Buy Rating as AMDS Wins Broader FDA Approval; Analyst Reiterates $36 Price Target
PremiumRatings
Artivion Earns Buy Rating as AMDS Wins Broader FDA Approval; Analyst Reiterates $36 Price Target
3M ago
AORT
Artivion: FDA Approval Expands AMDS Market Opportunity; Buy Rating Reiterated with Unchanged $44 Price Target
PremiumRatings
Artivion: FDA Approval Expands AMDS Market Opportunity; Buy Rating Reiterated with Unchanged $44 Price Target
3M ago
AORT
Artivion announces U.S. FDA approval of AMDS Hybrid Prosthesis
PremiumThe Fly
Artivion announces U.S. FDA approval of AMDS Hybrid Prosthesis
3M ago
AORT
Artivion Earnings Call Balances Growth With Caution
PremiumCompany Announcements
Artivion Earnings Call Balances Growth With Caution
5M ago
AORT
Artivion Completes Strategic Acquisition of Endospan Platform
PremiumCompany AnnouncementsArtivion Completes Strategic Acquisition of Endospan Platform
5M ago
8K
AORT
Endospan announces Artivion closed the transaction to acquire the company
Premium
The Fly
Endospan announces Artivion closed the transaction to acquire the company
5M ago
AORT
Artivion Shareholders Back Board, Pay and Auditor Choices
Premium
Company Announcements
Artivion Shareholders Back Board, Pay and Auditor Choices
5M ago
8K
AORT
3 Small-Cap Stocks with ‘Strong Buy’ Ratings and Big Upside in 2026
PremiumMarket News
3 Small-Cap Stocks with ‘Strong Buy’ Ratings and Big Upside in 2026
5M ago
DSP
AORT
Artivion price target lowered to $44 from $58 at Needham
PremiumThe Fly
Artivion price target lowered to $44 from $58 at Needham
5M ago
AORT
Artivion price target lowered to $45 from $55 at Lake Street
PremiumThe Fly
Artivion price target lowered to $45 from $55 at Lake Street
5M ago
AORT
Artivion price target lowered to $38 from $50 at Oppenheimer
PremiumThe Fly
Artivion price target lowered to $38 from $50 at Oppenheimer
5M ago
AORT
Artivion price target lowered to $45 from $55 at Stifel
PremiumThe FlyArtivion price target lowered to $45 from $55 at Stifel
5M ago
AORT
Artivion price target lowered to $36 from $48 at Canaccord
Premium
The Fly
Artivion price target lowered to $36 from $48 at Canaccord
5M ago
AORT
Artivion price target lowered to $48 from $53 at Citizens
Premium
The Fly
Artivion price target lowered to $48 from $53 at Citizens
5M ago
AORT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >